Profile data is unavailable for this security.
About the company
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.
- Revenue in USD (TTM)69.34bn
- Net income in USD18.90bn
- LocationPfizer Inc235 E 42ND STNEW YORK 10017-5703United StatesUSA
- Phone+1 (212) 573-2323
- Fax+1 (302) 655-5049
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|PFE:NYQ since |
|Trillium Therapeutics Inc||Deal completed||23 Aug 2021||23 Aug 2021Deal completed||10.84%||2.21bn|
|Glaxosmithkline Plc- Consumer Unit||Announced||03 Jun 2021||03 Jun 2021Announced||39.21%||--|
|Amplyx Pharmaceuticals Inc||Deal completed||28 Apr 2021||28 Apr 2021Deal completed||40.44%||--|